Living Liver and Kidney Donors

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Living Liver and Kidney Donors trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT03803423

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

This study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media and…

United States1,000 participantsStarted 2017-11-27

Treatment: The Donor App

All recent trials (12 shown)

TerminatedNot Applicable

NCT03865264

Living Organ Donor Recovery Enhancement Program

The purpose of the study is to test if using these living donor-specific pre-transplant resources would lead to a better and faster recovery post-transplant.

United States21 participantsStarted 2017-04-20

Treatment: Recovery Enhancement Program

CompletedNot Applicable

NCT06340607

Neohepatic Albumin-Bilirubin Scores on Renal Outcomes in Living-donor Liver Transplantation Recipients

This study investigates the association between post-reperfusion (neohepatic) ALBI scores and post-LT renal outcomes in living-donor LT (LDLT) recipients.

South Korea3,422 participantsStarted 2012-01-05

Living Liver and Kidney Donors

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

All recent trials (12 shown)

Living Organ Donor Recovery Enhancement Program

Neohepatic Albumin-Bilirubin Scores on Renal Outcomes in Living-donor Liver Transplantation Recipients

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

All recent trials (12 shown)

Living Organ Donor Recovery Enhancement Program

Neohepatic Albumin-Bilirubin Scores on Renal Outcomes in Living-donor Liver Transplantation Recipients

Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation

Impact of Dexmedetomidine on Acute Kidney Injury Following Living Donor Liver Transplantation

Renal and Cardiac Risk Factors of AKI After Liver Transplantation

Risk of Acute Kidney Injury in Living Liver Donor Surgery

Association of Intraoperative Renal Regional Oxygen Saturation and Acute Kidney Injury

Intraoperative Cerebral and Renal Tissue Oxygen Saturation and Pediatric Living Donor Liver Transplantation Prognosis.

Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants

Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney

Impact of %6 HES 130/0.4 and %4 Gelofusine Infusion on Kidney Function in the Living-donor Liver Transplantation